Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCDC192 encodes Coiled-coil domain-containing protein 192, a protein characterized by a coiled-coil domain that suggests a role in mediating protein-protein interactions[1][10]. The gene is protein coding and is assigned HGNC ID 49566. Expression has been detected in multiple human tissues, but the specific biological function remains unclear[5][7][10]. There is no reliable experimental evidence supporting its involvement in major cellular processes or diseases, except for a reported association with primary ciliary dyskinesia[3]. This protein is not currently recognized as a common drug target, nor is there evidence for direct therapeutic relevance[3][4][10]. Historical confusion regarding its aliases, especially "LINC01183," relates to previous gene symbol usage, but LINC01183 and CCDC192 are currently considered distinct entities under gene nomenclature guidelines[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 192 (CCDC192).